机构：[1]Translational Research Unit, Thoraxklinik at University of Heidelberg and Translational Lung Research Center (TLRC), Heidelberg/Germany,[2]Peking Union Medical College Hospital (PUMCH), Beijing/China,[3]University Hospital Bonn, Bonn/Germany,[4]The Netherlands Cancer Institute, Amsterdam/Netherlands,[5]Capital Medical University, Xuanwu Hospital, Beijing/ China,首都医科大学宣武医院[6]Hospital Clinic, University of Barcelona, Barcelona/Spain,[7]Roche Diagnostics GmbH, Penzberg/Germany,[8]Roche Diagnostics International Ltd, Rotkreuz/Switzerland
第一作者机构：[1]Translational Research Unit, Thoraxklinik at University of Heidelberg and Translational Lung Research Center (TLRC), Heidelberg/Germany,
通讯作者：
通讯机构：[2]Peking Union Medical College Hospital (PUMCH), Beijing/China,
推荐引用方式(GB/T 7714)：
Thomas Muley,Xiaotong Zhang,Stefan Holdenrieder,et al.Progastrin-Releasing Peptide (ProGRP) as a Biomarker for Clinical Response in Small-Cell Lung Carcinoma (SCLC)[J].JOURNAL OF THORACIC ONCOLOGY.2015,10(9):
APA：
Thomas Muley,Xiaotong Zhang,Stefan Holdenrieder,Catharina M. Korse,Xiu-Yi Zhi...&Felix Herth.(2015).Progastrin-Releasing Peptide (ProGRP) as a Biomarker for Clinical Response in Small-Cell Lung Carcinoma (SCLC).JOURNAL OF THORACIC ONCOLOGY,10,(9)
MLA：
Thomas Muley,et al."Progastrin-Releasing Peptide (ProGRP) as a Biomarker for Clinical Response in Small-Cell Lung Carcinoma (SCLC)".JOURNAL OF THORACIC ONCOLOGY 10..9(2015)
医学